The protein truncation test: A review

Human Mutation

Volumn 14, Issue 2, 1999, Pages 95-102

  Den Dunnen, Johan T ^a,b   Van Ommen, Gert Jan B ^b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hypermutable region; Mutation detection; Protein truncation test; RNA analysis; Screen

Indexed keywords

DNA; PROTEIN; RNA;

DNA DETERMINATION; DNA SEQUENCE; HUMAN; MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVIEW; RNA ANALYSIS;

BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDE CHAIN TERMINATION, TRANSLATIONAL; PROTEINS; RNA;

EID: 0032790612     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1004(1999)14:2<95::AID-HUMU1>3.0.CO;2-G     Document Type: Review

References (51)

1. Axton R, Hanson I, Danes S, Sellar G, Van Heyningen V, Prosser J.1997. The incidence of PAX6 mutation in patients with simple aniridia: an evaluation of mutation detection in 12 cases. J Med Genet 34:279-286.
2. Bal S, Kraus C, Wijnen J, Meera Khan P, Ballhausen WG. 1996. Multiple products in the protein truncation test due to alternative splicing in the adenomatous polyposis coli (APC) gene. Hum Genet 98:528-533.
3. Beaufrere L, Tuffery S, Hamel C, Bareil C, Arnaud B, Demaille J, Claustres M. 1997. The protein truncation test (PTT) as a method of detection for choroideremia mutations. Exp Eye Res 65:849-854.
4. Chang CC, Gould SJ. 1998. Phenotype-genotype relationships in complementation group 3 of the peroxisome-biogenesis disorders. Am J Hum Genet 63:1294-1306.
5. Culbertson MR. 1999. RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer. Trends Genet 15:74-80.
6. Dang M, Pulkkinen L, Smith FJ, McLean WH, Uitto J. 1998. Novel compound heterozygous mutations in the plectin gene in epidermolysis bullosa with muscular dystrophy and the use of protein truncation test for detection of premature termination codon mutations. Lab Invest 78:195-204.
7. De Koning Gans PAM, Ginjaar HB, Bakker E, Yates JRW, Den Dunnen JT. 1999. A protein truncation test for Emery-Dreifuss Muscular Dystrophy (EMD): detection of N-terminal truncating mutations. Neuromusc Disord 9:247-250.
8. Den Dunnen JT. 1996. Protein truncation test. In: Dracopoli NC, Haines JL, Korf BR, Moir DT, Morton CC, Seidman CE, Seidman JG, Smith DR, editors. Current protocols in human genetics. New York: John Wiley & Sons.
9. Eccles DM, Van Der Luijt RB, Breukel C, Bullman H, Bunyan D, Fisher A, Barber J, Du Boulay C, Primrose J, Burn J, Fodde R. 1996. Hereditary desmoid disease due to a fram shift mutation at codon 1924 of the APC gene. Am J Hum Genet 59:1193-1201.
10. Farrington SM, Lin-Goerke J, Ling J, Wang Y, Burczak JD, Robbins DJ, Dunlop MG. 1998. Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls. Am J Hum Genet 63:749-759.
11. Fitzgerald MG, Bean JM, Hegde SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, Isselbacher KJ, Haber DA. 1997. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nature Genet 15:307-310.
12. Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, Ponder BA, Anton-Culver H. 1997. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 60:313-319.
13. Gardner RJ, Bobrow M, Roberts RG. 1995. The identification of point mutations in Duchenne muscular dystrophy patients using reverse transcript PCR and the protein truncation test. Am J Hum Genet 57:311-320.
14. Heim RA, Kam-Morgan LNW, Binnie CG, Corns DD, Cayouette MC, Farber RA, Aylsworth AS, Silvennan LM, Luce MC. 1995. Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. Hum Mol Genet 4:975-981.
15. Hentze MW, Kulozik AE. 1999. A perfect message: RNA surveillance and nonsense-mediated decay. Cell 96:307-310.
16. Hogervorst FBL, Cornelis RS, Bout M, Van Vliet M, Oosterwijk JC Olmer R, Bakker E, Klijn JGM, Vasen HFA, Meijers-Heijboer H, Menko FH, Cornelisse CJ, Den Dunnen JT, Devilee P, Van Ommen GJB. 1995. Rapid detection of BRCA1 mutations by the protein truncation test. Nature Genet 10:208-212.
17. Hogervorst FBL, Van Der Tuijn AC, Poorthuis B, Kleyer W, Basker E, Van Ommen GJB, Den Dunnen JT. 1994. Rapid identification of mutations in the IDS-gene of Hunter patients: analysis of mRNA by the protein truncation test. Am J Hum Genet 55:A223.
18. Ishioka C, Frebourg T, Yan YX, Vidai M, Friend SH, Schmidt S, Iggo R. 1993. Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nature Genet 5:124-129.
19. Ishioka C, Suzuki T, FitzGerald M, Krainer M, Shimodaitra H, Shimada A, Nomizu T, Isselbacher KJ, Haber D, Kanamaru R. 1997. Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in yeast. Proc Natl Acad Sci USA 94:2449-2453.
20. Kobayashi T, Kuraoka I, Saijo M, Nakatsu Y, Tanaka A, Someda Y, Fukuro S, Tanaka K. 1997. Mutations in the XPD gene leading to xeroderma pigmentosum symptoms. Hum Mutat 9:322-331.
21. Kohonen-Corish M, Ross VL, Doe WF, Kool DA, Edkins E, Faragher I, Wijnen J, Khan PM, Macrae F, St John DJ. 1996. RNA-based mutation screening in hereditary nonpolyposis cobrectal cancer. Am J Hum Genet 59:818-824.
22. Kraus C, Gunther K, Vogler A, Hohenberger W, Pfeiffer RA, Ballhausen WG. 1998. Rapid RT-PCR-based protein truncation test in the screening for 5′ located mutations of the APC gene. Mol Cell Probes 12:143-147.
23. Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardiello FM, Hamilton SR, Hampel H, Markowitz A, Klimstra D, Jhanwar S, Winawer S, Offit K, Luce MC, Kinzler KW, Vogelstein B. 1997. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nature Genet 17:79-83.
24. Lakich D, Kazazian HHJ, Antonarakis SE, Gitschier J. 1993. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nature Genet 5:236-241.
25. Lamande SR, Bateman JF, Hutchison W, McKinlay Gardner RJ, Bower SP, Byrne E, Dahl HH. 1998. Reduced collagen VI causes Bethlem myopathy: a heterozygous COL6A1 nonsense mutation results in mRNA decay and functional haploinsufficiency. Hum Mol Genet 7:981-989.
26. Lancaster JM, Cochran CJ. 1996. Detection of BRCA1 mutations in women with early-onset ovarian cancer by use of the protein truncation test. J Natl Cancer Inst 88:552-554.
27. Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman RW, Berchuck A, Iglehart JD, Marks JR, Ashworth A, Stratton MR, Futreal PA. 1996. BRCA2 mutations in primary breast and ovarian cancers. Nature Genet 13:238-240.
28. Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L, Alon N, Wijker M, Parker L, Lightfoot J, Carreau M, Callen DF, Savoia A, Cheng NC, Van Berkel CGM, Strunk MHR Gille JJP, Pals G, Kruyt FAE, Pronk JC, Arwert F, Buchwald M, Joenje H. 1996. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nature Genet 14:320-323.
29. Maugard C, Margueritte G, Tuffery S, Rabesandratana H, Demaille J, Claustres M. 1997. Recurrent PIG-A mutation (IVS5+1G-→) in a paediatric case of paroxysmal nocturnal haemoglobinuria: detection by the protein truncation test. Br J Haematol 98:21-24.
30. Maugard C, Tuffery S, Aguilar-Martinez P, Schved JF, Gris JC, Demaille J, Claustres M. 1998. Protein truncation test: detection of severe haemophilia mutation and analysis of factor VIII transcripts. Hum Mutat 11:18-22.
31. Mazoyer S, Dunning AM, Serova O, Dearden J, Puget N, Healey CS, Gayther SA, Mangion J, Stratton MR, Lynch HT, Goldgar DE, Ponder BA, Lenoir GM. 1996. A polymorphic stop codon in BRCA2. Nature Genet 14:253-254.
32. Mears AJ, Gieser L, Yan D, Chen C, Fahrner S, Hiriyanna S, Fujita R, Jacobson SG, Sieving PA, Swaroop A. 1999. Protein-truncation mutations in the RP2 gene in a North American cohort of families with X-linked retinitis pigmentosa. Am J Hum Genet 64:897-900.
33. Ozcelik H, Schmocker B, Di Nicola N, Shi XH, Langer B, Moore M, Taylor BR, Narod SA, Darlington G, Andrulis IL, Gallinger S, Redston M. 1997. Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nature Genet 16:17-18.
34. Parry DM, MacCollin MM, Kaiser Kupfer MI, Pulaski K, Nicholson HS, Bolesta M, Eldridge R, Gusella JF. 1996. Germline mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. Am J Hum Genet 59:529-539.
35. Pegoraro E, Marks H, Garcia CA, Crawford T, Mancias P, Connolly AM, Fanin M, Martinello F, Trevisan CP, Angelini C, Stella A, Scavina M, Munk RL, Servidei S, Bonnemann CC, Bertorini T, Acsadi G, Thompson CE, Gagnon D, Hoganson G, Carver V, Zimmerman RA, Hoffman EP. 1998. Laminin alpha2 muscular dystrophy: genotype/phenotype studies of 22 patients. Neurology 51:101-110.
36. Peral B, Gamble V, Strong C, Ong AC, Sloane-Stanley J, Zerres K, Winearls CG, Harris PC. 1997. Identification of mutations in the duplicated region of the polycystic kidney disease 1 gene (PKD1) by a novel approach. Am J Hum Genet 60:1399-1410.
37. Petrij F, Giles RH, Dauwerse JG, Saris JJ, Hennekam RCM, Masuno M, Tommerup N, Van Ommen GJB, Goodman RH, Peters DJM, Breuning MH. 1995. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376:348-351.
38. Plummer SJ, Anton-Culver H, Webster L, Noble B, Liao S, Kennedy A, Belinson J, Casey G. 1996. Detection of BRCA1 mutations by the protein truncation test. Hum Mol Genet 4:1989-1991.
39. Powell SM, Petersen GM, Krush AAJ, Booker S, Jen J, Giardello FM, Hamilton SR, Vogelstein B, Kinzler KW. 1993. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 329:1982-1987.
40. Roelfsema JH, Spruit L, Saris JJ, Chang P, Pirson Y, Van Ommen GJB, Peters DJ, Breuning MH. 1997. Mutation detection in the repeated part of the PKD1 gene. Am J Hum Genet 61:1044-1052.
41. Roest PAM, Roberts RG, Sugino S, Van Ommen GJB, Den Dunnen JT. 1993. Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Hum Mol genet 2:1719-1721.
42. Romey MC, Tuffery S, Desgeorges M, Bienvenu T, Demaille J, Claustres M. 1996. Transcript analysis of CFTR frameshift mutations in lymphocytes using the reverse transcription-polymerase chain reaction technique and the protein truncation test. Hum Genet 98:328-332.
43. Rowan AJ, Bodmer WF. 1997. Introduction of a myc reporter tag to improve the quality of mutation detection using the protein truncation test. Hum Mutat 9:172-176.
44. Sobell JL, Lind TJ, Sigurdson DC, Zald DH, Snitz BE, Grove WM, Heston LL, Sommer SS. 1995. The D5 dopamine receptor gene in schizophrenia: identification of a nonsense change and multiple missense changes but lack of association with disease. Hum Mol Genet 4:507-514.
45. Van Bakel I, Sepp T, Ward S, Yates JR, Green AJ. 1997. Mutations in the TSC2 gene: analysis of the complete coding sequence using the protein truncation test (PTT). Hum Mol Genet 6:1409-1414.
46. Van De Vosse E, Franco B, Van Der Bent-Klootwijk P, Montini E, Orth U, Hanauer A, Tijmes N, Van Ommen GJB, Ballabio A, Den Dunnen JT, Bergen AAB. 1997. Exclusion of the PPEF gene as the gene causing X-linked juvenile retinoschisis. Hum Genet 101:235-237.
47. Van Der Luijt RB, Meera Kahn P, Vasen H, Van Leeuwen C, Tops C, Roest PAM, Den Dunnen JT, Fodde R. 1994. Rapid detection of translation-terminating mutations at the adenomatous polyposis coli (APC) gene by direct protein truncation test. Genomics 20:1-4.
48. Van Der Luijt RB, Meera Khan P, Vasen HFA, Tops CMJ, Van Leeuwen-Cornelisse ISJ, Wijnen JT, Van Der Klift HM, Plug RJ, Griffoen G, Fodde R. 1997. Molecular analysis of the APC gene in 105 Dutch kindreds with familial adenomatous polyposis: 67 germ-line mutations identified by DGGE, PTT and Southern analysis. Hum Mutat 9:7-16.
49. van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, van den Ouweland A, Halley D, Young J, Burley M, Jeremiah S. 1997. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805-808.
50. Whittock NV, Roberts RG, Mathew CG, Abbs SJ. 1997. Dystrophin point mutation screening using a multiplexed protein truncation test. Genet Testing 1:115-123.
51. Zou TT, Lei J, Shi YQ, Yin J, Wang S, Souza RF, Kong D, Shimada Y, Smolinski KN, Greenwald BD, Abraham JM, Harpaz N, Meltzer SJ. 1997. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC). Oncogene 15:101-105.